Page last updated: 2024-10-26

etidronate and Pseudohypoparathyroidism

etidronate has been researched along with Pseudohypoparathyroidism in 1 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Pseudohypoparathyroidism: A hereditary syndrome clinically similar to HYPOPARATHYROIDISM. It is characterized by HYPOCALCEMIA; HYPERPHOSPHATEMIA; and associated skeletal development impairment and caused by failure of response to PARATHYROID HORMONE rather than deficiencies. A severe form with resistance to multiple hormones is referred to as Type 1a and is associated with maternal mutant allele of the ALPHA CHAIN OF STIMULATORY G PROTEIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uttley, WS1
Belton, NR1
Syme, J1
Sheppard, H1

Other Studies

1 other study available for etidronate and Pseudohypoparathyroidism

ArticleYear
Calcium balance in children treated with diphosphonates.
    Archives of disease in childhood, 1975, Volume: 50, Issue:3

    Topics: Adenosine Monophosphate; Adrenocorticotropic Hormone; Bone and Bones; Calcinosis; Calcium; Child; Ch

1975